期刊文献+

Protective Effect of Telmisartan on Endothelial Cells Exposed to High Glucose Levels in vitro

Protective Effect of Telmisartan on Endothelial Cells Exposed to High Glucose Levels in vitro
原文传递
导出
摘要 Objectives To investigate the effect of telmisartan on human umbilical vein endothelial cells (HUVEC) exposed to high glucose in vitro and the related mechanism. Methods HUVECs were incubated with telmisartan and glucose (5 mmol/L, 30 mmot/L) at 0 h, 12 h, 24 h, 36 h, 48 h, respectively. The level of malondialdehyde (MDA) and superoxide dismutase (SOD) in the supernatant of cultured endothelial cells was measured by thiobarbituric acid test and xanthine oxidase test. The expression of PPAR-γ was determined at 24 hour with Western blot technique. Results When the endothelial cells were cultured in high glucose environment, the MDA level was significantly increased, but the SOD activity and the protein expression of PPAR-γ were markedly decreased. However, the high glucose-induced effects were inhibited by telmisartan intervention. Conclusion Telmisartan can decrease oxidative stress and increase PPAR-γ expression of endothelial cells in high glucose environment. (S Chin J Cardio12009 ; 10 (4) : 222 -226) Objectives To investigate the effect of telmisartan on human umbilical vein endothelial cells (HUVEC) exposed to high glucose in vitro and the related mechanism. Methods HUVECs were incubated with telmisartan and glucose (5 mmol/L, 30 mmot/L) at 0 h, 12 h, 24 h, 36 h, 48 h, respectively. The level of malondialdehyde (MDA) and superoxide dismutase (SOD) in the supernatant of cultured endothelial cells was measured by thiobarbituric acid test and xanthine oxidase test. The expression of PPAR-γ was determined at 24 hour with Western blot technique. Results When the endothelial cells were cultured in high glucose environment, the MDA level was significantly increased, but the SOD activity and the protein expression of PPAR-γ were markedly decreased. However, the high glucose-induced effects were inhibited by telmisartan intervention. Conclusion Telmisartan can decrease oxidative stress and increase PPAR-γ expression of endothelial cells in high glucose environment. (S Chin J Cardio12009 ; 10 (4) : 222 -226)
出处 《South China Journal of Cardiology》 CAS 2009年第4期222-226,共5页 岭南心血管病杂志(英文版)
关键词 human umbilical vein endothelial cell (HUVEC) TELMISARTAN Malondialdehyde (MDA) superoxide dismutase (SOD) peroxisome proliferator activated receptors γ (PPAR-γ) human umbilical vein endothelial cell (HUVEC) telmisartan Malondialdehyde (MDA) superoxide dismutase (SOD) peroxisome proliferator activated receptors γ (PPAR-γ)
  • 相关文献

参考文献10

  • 1Morawietz H.Beyond blood pressure:endothelial protection against hypercholester olemia by angioⅡtensinE type-1 receptor blockade[].Journal of Hypertension.2005 被引量:1
  • 2Olofsson EM,Marklund SL,Behndig A.Glucose-induced cataractin CuZn-SOD null lenses:An effect of nitric oxide[].Free Radical Biology and Medicine.2007 被引量:1
  • 3FN Ahmed,FN Naqvi,F Shafiq.Lipid peroxidation and serum antioxidant enzymes in patients with type 2 diabetes mellitus[].Annals of the New York Academy of Sciences.2006 被引量:1
  • 4Yu X,Li C,Li X,et al.Rosiglitazone prevents advanced glycation end products-induced renal toxicitylikely through suppression of plasmino-gen activator inhibitor-1[].Toxicological Sciences.2007 被引量:1
  • 5Ohga S,Shikata K,Yozai K,et al.Thiazolidinedione amelio-rates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB ac-tivation[].American Journal of Physiology Renal Physiology.2007 被引量:1
  • 6Tuck ML.Angiotensin-receptor blocking agents and the per- oxisome proliferator-activated receptor-gamma sys- tem[].MCurt Hypertens Rep.2005 被引量:1
  • 7Schupp M,Janke J,Clasen R,et al.Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity[].Circulation.2004 被引量:1
  • 8Satoh,M,Fujimoto,S,Haruna,Y.NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy[].American Journal of Physiology Renal Physiology.2005 被引量:1
  • 9Kurtz,T.W.New treatment strategies for patients with hypertension and insulin resistance[].The American Journal of Medicine.2006 被引量:1
  • 10Erbe DV,Gartrell K,ZhangYL,et al.Molecular activation of PPARgamma by angiotensin Ⅱ type 1-receptor antagonists[].Vascular Pharmacology.2006 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部